業績(2020~2021)

2021年度

• Igarashi E, Tani H, Tamura K, Itamochi M, Shimada T, Saga Y, Inasaki N, Hasegawa S, Yazawa S, Sasajima H, Kaya H, Nomura S, Itoh H, Takeda S, Yamamoto Y, Yamashiro S, Ichikawa T, Horie Y, Hirota K, Hirano N, Kawashiri C, Oishi K. Viral isolation analysis of SARS-CoV-2 from clinical specimens of COVID-19 patients. J Infect Chemother 28:347-51, 2022.https://doi.org/10.1016/j.jiac.2021.10.028
• 五十嵐笑子, 田村恒介, 板持雅恵, 稲崎倫子, 佐賀由美子, 嶌田嵩久, 川尻千賀子, 谷　英樹, 大石和徳, 彼谷裕康, 山本善裕, 野村　智, 竹田慎一, 廣田幸次郎, 伊藤博行, 市川智巳, 浦風雅春, 島多勝夫, 栂　博久, 明石拓也, 野田八嗣, 堀江幸男, 狩野恵彦, 山城清二, 平野典和, 東山考一. 富山県内新型コロナウイルス感染症患者からのウイルス分離解析.IASR 2021; 42: 18-20.https://www.niid.go.jp/niid/ja/diseases/ka/corona-virus/2019-ncov/2502-idsc/iasr-in/10303-494d03.html
• Igarashi E, Tani H, Tamura K, Itamochi M, Shimada T, Saga Y, Inasaki N, Hasegawa S, Yazawa S, Sasajima H, Kaya H, Nomura S, Itoh H, Takeda S, Yamamoto Y, Yamashiro S, Ichikawa T, Horie Y, Hirota K, Hirano N, Kawashiri C, and Oishi K. Viral isolation analysis of SARS-CoV-2 from clinical specimens of COVID-19 patients. J Infect Chemother. 2022; 28: 347-351.https://doi.org/10.1016/j.jiac.2021.10.028
• Morinaga Y, Tani H, Terasaki Y, Nomura S, Kawasuji H, Shimada T, Igarashi E, Saga Y, Yoshida Y, Yasukochi R, Kaneda M, Murai Y, Ueno A, Miyajima Y, Fukui Y, Nagaoka K, Ono C, Matsuura Y, Fujimura T, Ishida Y, Oishi K, Yamamoto Y. Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Emerging Variants. Microbiol Spectrum.https://doi.org/10.1128/spectrum.00560-21
• 矢澤俊輔, 五十嵐笑子, 板持雅恵, 稲崎倫子, 佐賀由美子, 川尻千賀子, 谷　英樹, 大石和徳, 彼谷裕康, 山本善裕, 野村　智, 竹田慎一, 廣田幸次郎, 伊藤博行, 市川智巳, 浦風雅春, 島多勝夫, 栂　博久, 明石拓也, 野田八嗣, 堀江幸男, 狩野恵彦, 山城清二, 平野典和, 東山考一. 新型コロナウイルス感染症患者鼻腔・鼻咽頭ぬぐい液および唾液検体における新型コロナウイルス分離培養の比較解析―富山県衛生研究所.IASR 2022; 43: 20-22.https://www.niid.go.jp/niid/ja/2019-ncov/2502-idsc/iasr-in/10933-503c01.html
• 矢澤俊輔, 五十嵐笑子, 板持雅恵, 稲崎倫子, 佐賀由美子, 川尻千賀子, 谷　英樹, 大石和徳, 四宮博人. 新型コロナウイルスオミクロン株のスクリーニングPCR法の検出感度の違いについて.IASR 2022; 43: 76-77.https://www.niid.go.jp/niid/ja/2019-ncov/2502-idsc/iasr-in/11051-505c02.html
• Itamochi M, Inasaki N, Saga Y, Shimada T, Obuchi M, Tani H, Mitsui C, Tomizawa T, Matsukura T, Takashima A, Seki E, Tanaka T, Doi Y, Kakiuchi T, Sasada K, Nakagawa M, Takeuchi T, Takamori T, Mizuki M, Morita M, Ishikawa T, Fujikawa M, Motoi I, Oishi K. Measles Transmission among Technical Interns from the Philippines in a Training Institute in Toyama Prefecture, Japan, in March 2019. Jpn J Infect Dis. 2021;74:255-258.https://doi.org/10.7883/yoken.jjid.2020.830
• Torii S, Miura F, Itamochi M, Haga K, Katayama K, Katayama H. Impact of the Heterogeneity in Free Chlorine, UV254, and Ozone Susceptibilities Among Coxsackievirus B5 on the Prediction of the Overall Inactivation Efficiency. Environ Sci Technol. 2021;55:3156-3164.https://doi.org/10.1021/acs.est.0c07796
• Kimura M, Egawa K, Ozawa T, Kishi H, Shimojima M, Taniguchi S, Fukushi S, Fujii H, Yamada H, Tan L, Sano K, Katano H, Suzuki T, Morikawa S, Saijo M, and Tani H. Characterization of Pseudotyped Vesicular Stomatitis Virus bearing the Heartland virus Envelope Glycoprotein. Virology. 2021; 556: 124-132.https://doi.org/10.1016/j.virol.2020.10.006
• Kandeel M, Yamamoto M, Tani H, Kobayashi A, Gohda J, Kawaguchi Y, Park B. K., Kwon H-J, Inoue J, Alkattan A. Discovery of new fusion inhibitor peptides against SARS-CoV-2 by targeting the Spike S2 subunit. Biomol Ther (Seoul). 2021; 29: 282-289.https://doi.org/10.4062/biomolther.2020.201
• Kawasuji H, Morinaga Y, Tani H, Kimura M, Yamada H, Yoshida Y, Takegoshi Y, Kaneda M, Murai Y, Kimoto K, Ueno A, Miyajima Y, Kawago K, Fukui Y, Sakamaki I, Yamamoto Y. Delayed neutralizing antibody response in acute phase correlates with severe progression of COVID-19. Sci Rep. 2021; 11: 16535.https://doi.org/10.1038/s41598-021-96143-8
• Yamada H, Taniguchi S, Shimojima M, Tan L, Kimura M, Morinaga Y, Fukuhara T, Matsuura Y, Komeno T, Furuta Y, Saijo M and Tani H. M Segment-Based Minigenome System of Severe Fever with Thrombocytopenia Syndrome Virus as a Tool for Antiviral Drug Screening. Viruses. 2021; 13: 1061.https://doi.org/10.3390/v13061061
• Morinaga Y, Tani H, Terasaki Y, Nomura S, Kawasuji H, Shimada T, Igarashi E, Saga Y, Yoshida Y, Yasukochi R, Kaneda M, Murai Y, Ueno A, Miyajima Y, Fukui Y, Nagaoka K, Ono C, Matsuura Y, Fujimura T, Ishida Y, Oishi K, Yamamoto Y. Correlation of the commercial anti-SARS-CoV-2 receptor binding domain antibody test with the chemiluminescent reduction neutralizing test and possible detection of antibodies to emerging variants. Microbiol Spectr. 2021; 9: e0056021.https://doi.org/10.1128/spectrum.00560-21
• Kawasuji H, Morinaga Y, Tani H, Saga Y, Kaneda M, Murai Y, Ueno A, Miyajima Y, Fukui Y, Nagaoka K, Ono C, Matsuura Y, Niimi H, Yamamoto Y. Age-dependent reduction in neutralization against alpha and beta variants of BNT162b2 SARS-CoV-2 vaccine-induced immunity. Microbiol Spectr. 2021; 9: e0056121.https://doi.org/10.1128/spectrum.00561-21
• Kawasuji H, Morinaga Y, Tani H, Yoshida Y, Takegoshi Y, Murai Y, Kimoto K, Ueno A, Miyajima Y, Kawago K, Fukui Y, Kimura M, Yamada H, Sakamaki I, Yamamoto Y. SARS-CoV-2 RNAemia with higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19. J Med Virol. 2022; 94: 147-153.https://doi.org/10.1002/jmv.27282

2020年度

• 板持雅恵, 稲崎倫子, 佐賀由美子, 嶌田嵩久, 五十嵐笑子, 名古屋真弓, 米田哲也, 長谷川澄代, 田村恒介, 谷　英樹, 前西絵美, 内田　薫, 金谷潤一, 磯部順子, 綿引正則, 木全恵子, 川尻千賀子, 大石和徳, 関塚剛史, 黒田　誠, 富山県COVID-19疫学研究グループ：彼谷裕康, 山本善裕, 野村　智, 竹田慎一, 廣田幸次郎, 伊藤博行, 市川智巳, 浦風雅春, 島多勝夫, 栂　博久, 明石拓也, 野田八嗣, 堀江幸男, 狩野恵彦, 山城清二, 富山県厚生部健康課, 新川厚生センター, 高岡厚生センター, 砺波厚生センター, 中部厚生センター, 富山市保健所. 富山県における新型コロナウイルス感染症（COVID-19）のゲノム解析所見（2020年3月30日～5月18日）. 病原微生物検出情報(IASR) 2020; 4, 188-190.https://www.niid.go.jp/niid/ja/diseases/ka/corona-virus/2019-ncov/2502-idsc/iasr-in/9931-488d02.html
• Torii S, Itamochi M, Katayama H: Inactivation kinetics of waterborne virus by ozone determined by a continuous quench flow system. Water Res. 186:116291, 2020.https://doi.org/10.1016/j.watres.2020.116291
• Taniguchi S, Yoshikawa T, Shimojima M, Fukushi S, Kurosu T, Tani H, Fukuma A, Kato F, Nakayama E, Maeki T, Tajima S, Lim CK, Ebihara H, Kyuwa S, Morikawa S, Saijo M. Analysis of the Function of the Lymphocytic Choriomeningitis Virus S Segment Untranslated Region on Growth Capacity In Vitro and on Virulence In Vivo. Viruses. 12(8):E896, 2020.https://doi.org/10.3390/v12080896
• Sekimukai H, Iwata-Yoshikawa N, Fukushi S, Tani H, Kataoka M, Suzuki T, Hasegawa H, Niikura K, Arai K, Nagata N. Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs. Microbiol Immunol. 64(1): 33-51, 2020.https://doi.org/10.1111/1348-0421.12754